Theravance Biopharma TBPH Increase (Decrease) in Other Operating Assets
Increase (Decrease) in Other Operating Assets at other companies
Other financials
Where this comes from
Reported directly by Theravance Biopharma in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingAssets.
The official record: Theravance Biopharma’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Theravance Biopharma's increase (decrease) in other operating assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Theravance Biopharma's increase (decrease) in other operating assets?
- Theravance Biopharma (TBPH) reported increase (decrease) in other operating assets of -$1.03M in Q1 2026.
- How has Theravance Biopharma's increase (decrease) in other operating assets changed year-over-year?
- Theravance Biopharma's increase (decrease) in other operating assets decreased by 210.6% year-over-year, from -$330K to -$1.03M.
- What is the long-term trend for Theravance Biopharma's increase (decrease) in other operating assets?
- Over 2 years (2021 to 2023), Theravance Biopharma's increase (decrease) in other operating assets has grown at a 10.7% compound annual growth rate (CAGR), from $1.01M to $1.23M.
- What does increase (decrease) in other operating assets mean?
- This captures the net change in miscellaneous assets that are not classified as loans, securities, or property, plant, and equipment. It often includes items like accrued interest receivables, prepaid expenses, and other short-term operational assets.